According to Hester Biosciences 's latest financial reports and stock price the company's current Operating Margin is 19.97%. At the end of 2022 the company had an Operating Margin of 23.86%.
Year | Operating Margin | Change |
---|---|---|
2022 | 23.86% | -8.94% |
2021 | 26.20% | 0.65% |
2020 | 26.04% | -25.42% |
2019 | 34.91% | 18.89% |
2018 | 29.36% | 7.72% |
2017 | 27.26% | -0.95% |
2016 | 27.52% | 17.38% |
2015 | 23.44% | -16.58% |
2014 | 28.10% | 4.67% |
2013 | 26.85% | -12% |
2012 | 30.51% | -6.61% |
2011 | 32.67% | 2.5% |
2010 | 31.87% | -12.93% |
2009 | 36.60% | -11.93% |
2008 | 41.57% | 5.08% |
2007 | 39.55% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.